Asia Pacific Oligosaccharides In Infant Nutrition Market
Market Size in USD Billion
CAGR :
% 
USD
1.80 Billion
USD
3.76 Billion
2025
2033
 Forecast Period |
2026 –2033 |
 Market Size (Base Year) |
USD 1.80 Billion |
 Market Size (Forecast Year) |
USD 3.76 Billion |
 CAGR |
% |
| Major Markets Players |
|
Asia-Pacific Oligosaccharides in Infant Nutrition Market Size
- The Asia-Pacific oligosaccharides in infant nutrition market size was valued at USD 1.80 billion in 2025 and is expected to reach USD 3.76 billion by 2033, at a CAGR of 9.65% during the forecast period
- The market growth is largely fuelled by the increasing awareness of the health benefits of human milk oligosaccharides (HMOs) and their role in supporting infant gut health and immune development
- Rising demand for premium infant formula products and the growing focus on replicating the nutritional composition of human breast milk are further accelerating the adoption of oligosaccharides in infant nutrition formulations
Asia-Pacific Oligosaccharides in Infant Nutrition Market Analysis
- The market is experiencing steady growth driven by continuous research and development activities focused on improving the functionality and production efficiency of oligosaccharides used in infant formula products
- Increasing investments by infant nutrition manufacturers to develop advanced formulations enriched with HMOs and other prebiotic ingredients are contributing to product innovation and expanding the global market presence of oligosaccharides in infant nutrition products
- China oligosaccharides in infant nutrition market accounted for the largest market revenue share in 2025, attributed to the country's expanding infant nutrition industry and rising demand for premium infant formula products
- Japan is expected to witness the highest compound annual growth rate (CAGR) in the Asia-Pacific oligosaccharides in infant nutrition market due to increasing consumer focus on functional nutrition for infants, high acceptance of technologically advanced infant formulas, and strong regulatory support for nutritional innovations. The rising preference for scientifically formulated products to enhance immunity, digestive health, and cognitive development in infants is further accelerating market adoption
- The human milk oligosaccharides segment held the largest market revenue share in 2025 driven by the increasing demand for infant formulas that closely replicate the functional properties of human breast milk. Human milk oligosaccharides are widely adopted due to their ability to support gut microbiota development, strengthen infant immunity, and improve digestive health, making them a preferred ingredient among infant nutrition manufacturers
Report Scope and Asia-Pacific Oligosaccharides in Infant Nutrition Market Segmentation
|
Attributes |
Asia-Pacific Oligosaccharides in Infant Nutrition Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
Asia-Pacific
|
|
Key Market Players |
• Yakult Honsha Co., Ltd. (Japan) |
|
Market Opportunities |
• Rising Demand For Premium Infant Nutrition Products |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Asia-Pacific Oligosaccharides in Infant Nutrition Market Trends
“Rising Demand for Human Milk Oligosaccharides in Infant Formula”
• The increasing emphasis on improving infant gut health and immunity is significantly shaping the oligosaccharides in infant nutrition market, as manufacturers aim to replicate the functional benefits of human breast milk in infant formula. Human milk oligosaccharides (HMOs) are gaining traction due to their role in promoting beneficial gut microbiota, supporting immune system development, and enhancing nutrient absorption. This trend is encouraging infant nutrition companies to incorporate advanced oligosaccharide ingredients into formula products to improve nutritional outcomes for infants
• Growing awareness among parents and healthcare professionals regarding the benefits of HMOs and other prebiotic oligosaccharides has accelerated their demand in premium infant nutrition products. These ingredients support digestive health and help reduce the risk of infections in early life stages. As a result, infant formula manufacturers are increasingly focusing on fortifying their products with scientifically validated oligosaccharides to enhance product differentiation and meet evolving consumer expectations
• Technological advancements in biotechnology and fermentation processes are enabling large-scale and cost-effective production of oligosaccharides for infant nutrition applications. Companies are investing in innovative production techniques to improve the availability and quality of HMOs used in infant formulas. These advancements are supporting the development of next-generation infant nutrition products that closely mimic the composition of human breast milk
• For instance, in 2024, Nestlé and Abbott expanded their infant formula portfolios by incorporating advanced HMO ingredients designed to support gut microbiome development and immune health in infants. These formulations were developed based on scientific research highlighting the benefits of oligosaccharides in early-life nutrition and were introduced to enhance the functional value of infant formula products. The launches strengthened product competitiveness and increased consumer confidence in scientifically formulated infant nutrition solutions
• While demand for oligosaccharides in infant nutrition is growing, sustained market expansion depends on continued clinical research, regulatory approvals, and improving production efficiency. Manufacturers are also focusing on developing new oligosaccharide variants and optimizing fermentation technologies to ensure consistent quality, safety, and scalability for global infant nutrition markets
Asia-Pacific Oligosaccharides in Infant Nutrition Market Dynamics
Driver
“Increasing Focus on Infant Gut Health and Immune Development”
• Rising awareness regarding the importance of early-life nutrition is a major driver for the oligosaccharides in infant nutrition market. Parents and healthcare professionals are increasingly recognizing the role of HMOs in supporting healthy gut microbiota and strengthening the immune system of infants. This has encouraged infant formula manufacturers to incorporate functional oligosaccharides to enhance the nutritional profile of their products
• Expanding demand for premium infant nutrition products is also influencing market growth. Consumers are increasingly seeking formulas that closely resemble the composition and health benefits of human breast milk. Oligosaccharides help improve digestive health, support immune responses, and promote the growth of beneficial bacteria in infants, making them an essential component in modern infant nutrition formulations
• Infant nutrition companies are actively investing in research, clinical trials, and product innovation to expand the application of oligosaccharides in infant formula. These initiatives are supported by collaborations between biotechnology companies and infant nutrition brands to develop scientifically validated ingredients with enhanced health benefits
• For instance, in 2023, FrieslandCampina Ingredients and DSM-Firmenich reported increased adoption of HMO ingredients in infant formula products designed to support digestive health and immune system development. These developments followed growing scientific evidence highlighting the benefits of oligosaccharides in early nutrition, strengthening product innovation and differentiation in the infant nutrition industry
• Although increasing demand for functional infant nutrition products supports market growth, long-term expansion will depend on improving ingredient availability, optimizing production processes, and ensuring regulatory compliance across different markets. Continuous research and technological innovation will be critical to enhancing the functional performance and accessibility of oligosaccharides in infant nutrition products
Restraint/Challenge
“High Production Costs and Regulatory Complexity”
• The relatively high cost of producing oligosaccharides, particularly HMOs, remains a key challenge for the infant nutrition market. Complex fermentation and purification processes required for manufacturing these ingredients significantly increase production costs. This can limit widespread adoption among manufacturers seeking cost-effective alternatives in infant formula formulations
• Regulatory requirements for infant nutrition ingredients are stringent, requiring extensive safety testing, clinical validation, and approval from regulatory authorities before commercialization. These regulatory processes can increase development timelines and limit the introduction of new oligosaccharide variants in infant formula products
• Supply chain and manufacturing challenges also influence market growth, as oligosaccharide production requires specialized biotechnology infrastructure and strict quality control measures. Maintaining consistency in ingredient purity, stability, and safety adds additional operational complexity for manufacturers
• For instance, in 2024, several infant nutrition product developers reported challenges in scaling HMO production due to high fermentation costs and strict regulatory requirements for infant nutrition ingredients. These factors also increased development timelines for new formula products containing advanced oligosaccharides, affecting the pace of market expansion
• Overcoming these challenges will require investment in advanced biotechnology processes, improved fermentation efficiency, and stronger collaboration between ingredient producers and infant nutrition manufacturers. Developing cost-efficient production technologies and streamlining regulatory approval processes will be essential to unlocking the long-term growth potential of the global oligosaccharides in infant nutrition market
Asia-Pacific Oligosaccharides in Infant Nutrition Market Scope
The Asia-Pacific oligosaccharides in infant nutrition market is segmented on the basis of source, type, and form.
• By Type
On the basis of type, the Asia-Pacific oligosaccharides in infant nutrition market is segmented into Galactoligosaccharides, Human Milk Oligosaccharides, and Fructooligosaccharides. The human milk oligosaccharides segment held the largest market revenue share in 2025 driven by the increasing demand for infant formulas that closely replicate the functional properties of human breast milk. Human milk oligosaccharides are widely adopted due to their ability to support gut microbiota development, strengthen infant immunity, and improve digestive health, making them a preferred ingredient among infant nutrition manufacturers.
The galactoligosaccharides segment is expected to witness the fastest growth rate from 2026 to 2033, driven by their strong prebiotic properties and increasing application in infant formula products. These ingredients help promote the growth of beneficial gut bacteria and enhance nutrient absorption, making them increasingly popular in advanced infant nutrition formulations designed to support early-life digestive health.
• By Source
On the basis of source, the Asia-Pacific oligosaccharides in infant nutrition market is segmented into Bacteria, Plants, Algae, and Fungi. The bacteria segment held the largest market revenue share in 2025 driven by the growing use of microbial fermentation technologies to produce complex oligosaccharides at commercial scale. Bacteria-derived oligosaccharides enable manufacturers to produce high-purity ingredients efficiently, supporting the development of innovative infant nutrition products with improved functional benefits.
The algae segment is expected to witness the fastest growth rate from 2026 to 2033, driven by increasing research activities focused on discovering new bioactive compounds from marine sources. Algae-derived oligosaccharides are gaining attention due to their potential nutritional benefits and sustainable sourcing, making them an emerging ingredient category in advanced infant nutrition formulations.
• By Form
On the basis of form, the Asia-Pacific oligosaccharides in infant nutrition market is segmented into Liquid and Powder. The powder segment held the largest market revenue share in 2025 driven by its longer shelf life, ease of storage, and compatibility with infant formula manufacturing processes. Powdered oligosaccharides are widely used by infant nutrition manufacturers for their stability and convenience in large-scale production and product formulation.
The liquid segment is expected to witness the fastest growth rate from 2026 to 2033, driven by increasing demand for ready-to-use infant nutrition solutions and liquid-based formula products. Liquid oligosaccharide formulations allow easier blending in certain specialized infant nutrition products, supporting their growing adoption among manufacturers focused on product innovation and convenience.
Asia-Pacific Oligosaccharides in Infant Nutrition Market Regional Analysis
- China oligosaccharides in infant nutrition market accounted for the largest market revenue share in 2025, attributed to the country's expanding infant nutrition industry and rising demand for premium infant formula products
- Parents are increasingly prioritizing infant health and nutrition, encouraging the adoption of formula products enriched with functional ingredients such as human milk oligosaccharides
- The strong presence of domestic and international infant nutrition manufacturers, combined with increasing product innovation, is significantly contributing to the expansion of the oligosaccharides market in China
Japan Oligosaccharides in Infant Nutrition Market Insight
The Japan oligosaccharides in infant nutrition market is expected to witness the fastest growth rate from 2026 to 2033 due to increasing awareness regarding early-life nutrition and strong demand for advanced infant formula products. Consumers in the country place a high emphasis on scientifically validated and high-quality nutritional ingredients. The growing focus on infant digestive health, combined with continuous innovation in functional nutrition, is encouraging manufacturers to incorporate oligosaccharides into infant formula products, supporting steady market growth.
Asia-Pacific Oligosaccharides in Infant Nutrition Market Share
The Asia-Pacific oligosaccharides in infant nutrition industry is primarily led by well-established companies, including:
• Yakult Honsha Co., Ltd. (Japan)
• Meiji Holdings Co., Ltd. (Japan)
• Morinaga Milk Industry Co., Ltd. (Japan)
• Nissin Sugar Co., Ltd. (Japan)
• Mitsubishi Corporation Life Sciences Limited (Japan)
• Kerry Group (Asia-Pacific Operations) (Singapore)
• Wuxi Cima Science Co., Ltd. (China)
• Baolingbao Biology Co., Ltd. (China)
• Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (China)
• Quantum Hi-Tech (China) Biological Co., Ltd. (China)
• Ace Biotechnology Co., Ltd. (China)
• Bigtree Group Co., Ltd. (China)
• AIDP Asia Co., Ltd. (Singapore)
• Jiangsu Zipin Biological Technology Co., Ltd. (China)
• Zhejiang Huakang Pharmaceutical Co., Ltd. (China)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Asia Pacific Oligosaccharides In Infant Nutrition Market, Supply Chain Analysis and Ecosystem Framework
To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Asia Pacific Oligosaccharides In Infant Nutrition Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Asia Pacific Oligosaccharides In Infant Nutrition Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
